Effect of Diallyl Disulphide on Diabetes Induced Dyslipidemia in Male Albino Rats
Correspondence Address :
Dr. Naveen Kumar Sambu,
Lecturer, Department of Biochemistry, RIMS, Hyderabad Road, Raichur, Karnataka-584102, India.
E-mail : sambu_naveen@yahoo.com
Background: Diabetes Mellitus is a chronic metabolic disorder which may lead to various complications, the important being dyslipidemia leading to Coronary Heart Disorders (CHD), the major cause for morbidity and mortality in diabetic patients. Diabetes Mellitus could be treated by nutritional therapy/drug therapy and others. But the drug therapy would have its own limitations and side effects. To overcome from this an herbal extract is recommended, such as Diallyl Disulphide (DADS) a principle compound of Garlic oil. A im: To assess the hypolipidemic effect of Diallyl Disulphide (DADS) in alloxan induced diabetic rats.
Materials and Methods: Healthy adult wistar strain male albino rats weighing around 100-150 grams were randomly selected from the animal house at BLDE University’s Shri B.M.Patil Medical College, Hospital and Research Centre, Bijapur, India. Diabetes was induced using alloxan and was treated with DADS. After a stipulated time the rats were anesthetised and sacrificed to collect the blood and liver tissue. Various Lipid parameters, HMG CoA Reductase, Fecal bile acids were estimated in the blood, feces and homogenised liver tissue using standard procedures. S tatiscal Analysis: One-way ANOVA followed by post-hoc t-test is done.
Result: There was significant decrease in the blood and liver tissue lipid parameters of DADS treated alloxan induced diabetic rats when compared to the alloxan induced diabetic rats.
Conclusion: From this study it can be concluded that the DADS a principle compound of garlic, definitely has the hypolipidemic effect in diabetic rats, which is reducing the morbidity in diabetic cases due to dyslipidemia without the adverse effects.
Diabetes mellitus, Dyslipidemia, HMG CoA Reductase
DOI: 10.7860/JCDR/2015/13374.5860
Date of Submission: Feb 06, 2015
Date of Peer Review: Mar 19, 2015
Date of Acceptance: Mar 25, 2015
Date of Publishing: Apr 01, 2015
Financial OR OTHER COMPETING INTERESTS: None.
- Emerging Sources Citation Index (Web of Science, thomsonreuters)
- Index Copernicus ICV 2017: 134.54
- Academic Search Complete Database
- Directory of Open Access Journals (DOAJ)
- Embase
- EBSCOhost
- Google Scholar
- HINARI Access to Research in Health Programme
- Indian Science Abstracts (ISA)
- Journal seek Database
- Popline (reproductive health literature)
- www.omnimedicalsearch.com